Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Brain Neoplasms 4Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioma 1Fatigue 1Burkitt Lymphoma 1

Interventions

Etoposide 27Carboplatin 26atezolizumab 16durvalumab 12Cisplatin 10Topotecan 9Drug Therapy 9PM 01183 7pembrolizumab 5Radiotherapy 5Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Irinotecan 4Injections 4Immunotherapy 4trilaciclib 3toripalimab 3Temozolomide 3Radiosurgery 3Bevacizumab 3AMG 757 3tislelizumab 2monalizumab 2irinotecan sucrosofate 2enzalutamide 2apatinib 2Platinum 2Nivolumab 2Itraconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Small Cell Lung Carcinoma × Mental Status and Dementia Tests × Clear all
NCT04804644 2026-05-04

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

NRG Oncology

Phase 3 Recruiting
200 enrolled
CNSThoracic

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡